207_Combined course Presentations

PCR

• The Radiation Therapy Oncology Group (RTOG) 0247 (A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer)